Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

1.3K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K
Human Genetics01:28

Human Genetics

1.8K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.8K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

75
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Crust Composition and the Shallow Heat Source in KS 1731-260.

Physical review letters·2025
Same author

Large-scale analysis of structural brain asymmetries during neurodevelopment: Associations with age and sex in 4265 children and adolescents.

Human brain mapping·2024
Same author

The relationship between the size and asymmetry of the lateral ventricles and cortical myelin content in individuals with mood disorders.

medRxiv : the preprint server for health sciences·2024
Same author

The Gender Euphoria Scale (GES): a protocol for developing and validating a tool to measure gender euphoria in transgender and gender diverse individuals.

Frontiers in psychology·2024
Same author

Testing of putative antiseizure drugs in a preclinical Dravet syndrome zebrafish model.

bioRxiv : the preprint server for biology·2023
Same author

Generalization of procedural motor sequence learning after a single practice trial.

NPJ science of learning·2023

Related Experiment Video

Updated: Mar 22, 2026

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

11.1K

Separating the wheat from the chaff: systematic identification of functionally relevant noncoding variants in ADHD.

J H S Tong1, Z Hawi1, C Dark1

  • 1School of Psychological Sciences and Monash Institute for Cognitive and Clinical Neurosciences, Monash University, Melbourne, VIC, Australia.

Molecular Psychiatry
|April 27, 2016
PubMed
Summary

Identifying genetic risk for attention deficit hyperactivity disorder (ADHD) is key. This study prioritizes noncoding DNA variants, finding 65 with functional annotations for future ADHD research and treatment development.

More Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K
Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.9K

Related Experiment Videos

Last Updated: Mar 22, 2026

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

11.1K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K
Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.9K

Area of Science:

  • Genetics
  • Neurobiology
  • Bioinformatics

Background:

  • Attention deficit hyperactivity disorder (ADHD) is a highly heritable psychiatric condition with significant negative lifetime impacts.
  • Understanding the genetic architecture of ADHD is crucial for neurobiological insights and developing novel treatments.
  • Previous research identified numerous potential genetic association signals, necessitating methods to distinguish true associations from false ones.

Purpose of the Study:

  • To identify and prioritize functionally relevant DNA variants associated with ADHD.
  • To develop a tractable shortlist of variants for experimental validation in ADHD research.
  • To highlight the importance of noncoding variants in ADHD genetic risk and propose a bioinformatics approach for psychiatric disorders.

Main Methods:

  • Defined a set of 2070 DNA variants associated with ADHD or in linkage disequilibrium.
  • Utilized genome-wide annotation tools (GWAVA, CADD) to prioritize noncoding variants based on pathogenicity.
  • Leveraged large-scale genomic datasets (ENCODE, NIH Roadmap) to assign functional annotations to prioritized variants.

Main Results:

  • Over 97% of the 2070 identified variants were noncoding.
  • Identified 65 variants with high likelihood of pathogenicity and assigned functional annotations (e.g., impact on splicing, transcription factor binding, translational regulation).
  • These 65 variants represent a promising shortlist for future experimental validation in ADHD.

Conclusions:

  • Noncoding variants play a significant role in the genetic risk of ADHD.
  • The study presents a robust bioinformatics approach for prioritizing functional variants in psychiatric disorders.
  • The identified 65 variants offer clear hypotheses for experimental investigation into ADHD's genetic underpinnings and potential therapeutic targets.